Grupo Ferrer instructs Deloitte on Tarbis Farma acquisition

Deloitte Legal advised Grupo Ferrer Internacional on the sale of Spain-based pharmaceutical company Tarbis Farma to Amarox, according to Mergermarket.

Amarox is a subsidiary of Indian pharmaceutical company Hetero Labs.

Tarbis Farma’s annual revenue is reportedly in the region of €11 million.

A total of 60 per cent of Barcelona-headquartered Grupo Ferrer’s sales are in Europe.

Ben Cook